Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06505941 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS

StatusNot Yet Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 17, 2024 (before its estimated November 20, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The object of this study is to observe the safety of umbilical cord mesenchymal stem cell therapy for acute respiratory distress syndrome, consisting with two phases.
Trial Details
NCT Number NCT06505941
Lead Sponsor Southeast University, China
Collaborators: Zhongda Hospital, Yinguan Biologics, Shenzheng
Conditions
(from sponsor)		 Acute Respiratory Distress Syndrome
Related terms Respiratory Distress Syndrome
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov